- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care
French breast-implant recall could sway U.S. device debate
January 19, 2012
Bloomberg NewsU.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like
their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
MoreRating doctors and other health care providers
January 14, 2012
Sam StallA new onslaught of Medicare data might shine more light on providers, but tricky questions abound.
MoreLilly's Zyprexa pact with health providers wins approval
January 12, 2012
Bloomberg NewsEli Lilly and Co. has won approval of a $4.5 million settlement with five union health funds and an insurer that alleged improper
marketing of the company's best-selling medication, Zyprexa, raised their costs.
MoreOnce-rising star AIT Laboratories now cutting jobs
January 11, 2012
Chris O'MalleyAIT Laboratories, one of the area’s fastest-growing companies in recent years, confirmed Tuesday that it is eliminating
jobs, but would not say how many. The company said it is restructuring.
MoreDrugmaker plans 234 Terre Haute jobs by 2016
January 10, 2012
IBJ Staff and Associated PressA California-based pharmaceutical company says it expects to hire 234 people by 2016 at a new operation on the site of a former
Pfizer Inc. drug plant near Terre Haute.
MorePressure rises as Lilly tries squeeze play
January 9, 2012
J.K. WallIndianapolis-based Eli Lilly and Co. is now in the predicament of watching revenue fall as its patents on older products expire,
even as the company needs to spend more money on marketing and research to boost sales of new drugs.
MoreBoston lawsuit claims DES-breast cancer link
January 8, 2012
Associated PressFifty-three women from around the country are suing drug companies, including Eli Lilly and Co., who made and promoted DES
for millions of pregnant women from about 1938 to the early 1970s.
MoreHealthx receives $22M capital infusion
January 6, 2012
Frontier Capital in Charlotte, N.C., provided the funding that will support the continued expansion of Healthx, a local provider
of online health care portals.
MoreLilly's 2012 earnings forecast misses analyst estimates
January 5, 2012
Bloomberg News, Associated PressIndianapolis-based Eli Lilly and Co. provided a 2012 earnings forecast Thursday morning that missed analyst estimates by a
wide margin, sending shares down.
MoreLilly challenging Biogen patent in London lawsuit
January 5, 2012
Bloomberg NewsEli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system
diseases.
MoreWellPoint, other insurers profit from health law they oppose
January 5, 2012
Insurance companies spent millions of dollars trying to defeat the U.S. health-care overhaul. But profit margins at the companies
have widened to levels not seen since before the recession, a Bloomberg Government study shows.
MoreEndocyte stays course despite being battered by investors
December 31, 2011
J.K. WallAfter spending most of 2011 as a Wall Street darling, the year ended ugly for Endocyte Inc. But CEO Ron Ellis thinks the West
Lafayette-based drug developer is in better position than ever.
MoreLilly losing dominance in diabetes treatment
December 31, 2011
J.K. WallEli Lilly and Co., after more than a decade of setbacks, is counting on diabetes to help it survive a string of patent losses
on other products that have begun to sap the drugmaker's sales.
MoreWalgreen expects to lose most Express Scripts biz
December 29, 2011
Associated PressDrugstore operator Walgreen Co. said Thursday it expects to lose almost 90 percent of prescriptions handled by pharmacy benefits
manager Express Scripts Inc. after it leaves Express Scripts' networks on Jan. 1.
MoreArcadia agrees to sell DailyMed to Walgreen
December 27, 2011
J.K. WallIt looks like Arcadia Resources Inc.’s DailyMed pharmacy business will live on—but under the wing of Walgreen
Co. instead of on its own.
MoreQ&A
December 27, 2011
J.K. WallDr. Bryan Schneider, a professor at the Indiana University School of Medicine, led a team of researchers in identifying genetic variations that dispose some breast cancer patients to neuropathy when they are receiving chemotherapy with the drug Taxol. Schneider’s research was named one of the biggest advances in cancer research this year by the American Society of Clinical Oncology. The society’s foundation also gave Schneider a three-year, $450,000 grant to further the research.
Franciscan among Medicare's first accountable care groups
December 19, 2011
J.K. WallFranciscan Alliance’s Indianapolis-area hospitals, along with more than 700 physicians, have been named one of the nation’s
first 32 accountable care organizations.
MoreHoosiers like parts of health reform law
December 19, 2011
J.K. WallAs it is in the rest of the country, the 2010 health reform in Indiana continues to be unpopular, unlikely to be repealed
and uncertain to put a dent in health spending, according to a poll of Hoosiers released last week by Ball State University.
MorePlanned Parenthood of Indiana brings on new lobbyists
December 17, 2011
IBJ StaffThe new hires could be important following last year’s legislative session, in which state lawmakers passed a law to
cut off Medicaid funding to groups that offer abortions.
MoreIndependent doctors fear loss of referrals
December 17, 2011
J.K. WallIndependent health care facilities, like Body One Physical Therapy, are seeing referrals from physicians beginning to slacken
as more and more doctors become employees of hospitals. The hospitals request that doctors send patients to their in-house
physical therapy practices.
MoreExpress Scripts, WellPoint in contract fight
December 13, 2011
Associated PressPharmacy benefits manager Express Scripts Inc. said Tuesday it is in the middle of a contract dispute with WellPoint Inc.,
one of the biggest health insurers in the United States.
MoreEndocyte shares plunge on clinical trial results
December 13, 2011
J.K. WallShares of Endocyte Inc. plummeted more than 60 percent Tuesday morning after clinical trial results showed the company’s
experimental ovarian cancer drug led to shorter survival times than treatment with a standard cancer drug.
MoreMedical Mutual eyes Indiana for growth
December 12, 2011
J.K. WallHealth insurer expects enrollment in its health plan to grow 30 percent next year, to nearly 21,000. And then it expects growth
of another 40 percent.
MoreBall State: Diabetes rising at alarming rate
December 12, 2011
J.K. WallIn 1993, only 3.8 percent of Hoosier adults had full-blown diabetes, compared with 9.8 percent today.
MoreLAMKIN: Solving health care woes with CO-OPs
December 10, 2011
Ned LamkinHealth costs remain the No. 1 cause of personal bankruptcy and the largest, most uncontrollable element for businesses. This
is unsustainable.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Who makes Tater Tots? They would be a good sponsor, because $3 Million for the alleged "Greatest Spectacle In Racing" is taters. Tiny, tiny taters. But at least they are making up something of the losses accumulated over the years in this dying sport. Buttock in seat is certainly not doing it, nor eyeball on TV, as evidenced by the lack of both.
We loved lakehouse and think the Arbor Village would be a great location. It is less than 2 miles from over 1000 rooftops in the 225,000 to over 1 million range. Many people could use the great fishers trail system to bike or walk there. Just an idea Scotty -- but maybe something closer to 3 Wiseman would good. The only microbrew in area is Ram (boring)
True, it's an ESPN production, but ESPN is just another name for ABC Sports, or what used to be ABC Sports since ABC Sports no longer exists as a name. ESPN=ABC Sports= ESPN. ESPN is, according to Forbes "the world's most valuable media property" worth $40 billion. Despite that, they fired 400 people this week.
The Prestige was a great flick.
Larry - even though the race is on ABC, ESPN does all of the work, so that is why ESPN is mentioned. Most sports on ABC are called something like "ESPN on ABC."